Skip to main content
Clinical Trials/CTRI/2022/06/043269
CTRI/2022/06/043269
Completed
Phase 2

A Randomized Clinical Trial to evaluate the efficacy of Khadirakramuka Kwath and Nishamlaki Per Orum with and without Nitya Virechana in the management of Pramehajanya Timira with special reference to Diabetic Macular Edema

ational Institute of Ayurveda0 sites30 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
ational Institute of Ayurveda
Enrollment
30
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
July 31, 2023
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Patients between 40\-70 years of age.
  • 2\.Diagnosed cases of Diabetes Mellitus Type 2\.
  • 3\.NPDR cases with Macular Edema.
  • 4\.Clinically significant Diabetic Macular
  • Edema of less than 12 months duration.
  • 5\.Visual acuity minimum 6/60 or better.
  • 6\.Patients having HbA1c levels upto 8\.

Exclusion Criteria

  • 1\.Hypertensive patients with systolic BP \>160
  • and diastolic BP \>95 mm Hg.
  • 2\.Patients having HbA1c levels greater than
  • 3\.Diabetic patients with cardiovascular
  • 4\.History of ocular surgery within 4 months
  • prior to enrolment.
  • 5\.Pregnant diabetic patients.
  • 6\.Patients with moderate to severe
  • cataractous changes.
  • 7\.Patients having a history of glaucoma or

Outcomes

Primary Outcomes

Not specified

Similar Trials